AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 221 min read$AFCG

TANNENBAUM LEONARD M purchased $35K of AFCG

TANNENBAUM LEONARD M purchased 10,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.49 on 2026-09-18.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Sep 22, 2026, 10:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 10:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AFCG
Neutral
high confidence
Mentioned
$AFCG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The purchase modestly raises the insider's ownership but is unlikely to move the stock.

02

Market read

Low relevance; small insider purchase with limited trading implications.

03

What to watch

Potential upcoming capital raise or partnership not disclosed.

Relevance 4/10Novelty 4/10Timing: filed 2026-09-22

Background

Form 4 filing reports insider transactions for publicly traded companies.

Company-level read

Ticker impact

$AFCGNeutralHigh confidence
Context

Director Leonard Tannenbaum bought 10,000 shares for $34,900, increasing his stake in Advanced Flower Capital.

Expected impact

Minimal price movement expected.

Evidence & confidence

Form 4 filing is primary source; transaction size is modest relative to float.

Market effects

Sector

None significant for the cannabis sector.

Regional

No regional effect.

Global

Limited to AFCG shareholders.

Counterpoint

What could challenge this read

Insider buying could be a precursor to upcoming positive news.

Key entities

  • Company
    Advanced Flower Capital Inc.

    Issuer of the Form 4 filing.

  • Individual
    Leonard Tannenbaum

    Director and 10% owner of AFCG.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AFCG insider trading history →

Related articles

AUG 20
$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

fool.com3 min
AUG 13
$AFCGMed

Advanced Flower Capital Inc. (AFCG): AFC Announces Financial Results for the Second Quarter 2026

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

SEC EDGAR 8-K6 min
JUL 15
$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.

manilatimes.net3 min